FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Conservative super PAC drops six-figure ad buy in major move to defend Trump’s trifecta

EXCLUSIVE: Trump to center SOTU on working families with sweeping economic case

Good Samaritans Help Chicago Family Recover Stolen Dog

Potential ’28 Presidential Candidate Gavin Newsom Continues to Backtrack on Trans Sports Debate

Missouri suspect taken into custody after deputy fatally shot, ending manhunt

California allocating $35M to support illegal immigrants amid Trump’s mass deportation agenda

Biden friends voice concern over increased fatigue amid cancer battle: report

Manhunt underway after Missouri deputy slain, suspect’s truck spotted heading toward Arkansas border

House Dem compares Trump’s illegal immigration crackdown to ‘terrorism,’ vows to abolish ICE

Abbott surges Texas troopers to border after cartel kingpin’s killing sparks violence in Mexico

‘Sadistic’ man charged after allegedly luring 13-year-old to motel for sex in twisted online plot

Notorious Mexican Drug Lord Was Killed After Secret Rendezvous with Lover Went Awry

California Gov. Gavin Newsom Accused of Racism After Making SAT Score Comment to Black Mayor

Mamdani’s NYC: Mayor Says Deaths During ‘Historic’ Blizzard Were ‘Overdose Related’ and Not Due to Weather Conditions

Social media erupts after Stephen King makes false claim about Trump’s family: ‘What is this sh–?’

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”